Merck has become the latest drugmaker to limit discounts on 340B drugs, saying it will stop giving 340B discounts on certain drugs unless hospitals provide claims data. The drugmaker sent a letter Aug ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Taken together, Merck, Eli Lilly ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results